Board of Directors

Rich DiIorio assumed the role of chief executive officer of InfuSystem in November 2017 and serves as a member of the Company’s board of directors.

Rich joined InfuSystem in January 2004 starting out as a territory manager before his promotion to vice president of oncology sales. Prior to his appointment to CEO, Rich most recently served as executive vice president and general manager of oncology. During his tenure with the Company, Rich has received numerous awards and honors, and has recorded several podcasts for aspiring leaders sharing his journey to CEO. He is a fierce champion of people; bringing out the best in teams through empowerment and recognition.

Prior to joining the Company, Rich held various sales and leadership roles at Stryker Medical, Novartis Pharmaceuticals and Thermo Scientific. He earned a Bachelor of Science degree in Biology from Boston College and lives in southern Massachusetts with his wife, Sue and 2 sons. Rich shares his love of baseball with his sons; both as a coach and a spectator.

Carrie Lachance joined InfuSystem in 2010 and currently serves as the Company’s president & chief operating officer (COO). Carrie was  appointed to the Company’s Board of Directors in May 2021. Prior to her appointment in this capacity, Carrie spent the prior two years serving as Executive Vice President & COO. Prior to her executive appointment, Carrie held numerous positions with the Company including management roles in Clinical Resources and Clinical Sales. Carrie brings extensive clinical knowledge from more than 20 years in the medical field. Her medical career began in 1996 as a Hospital Corpsman in the U.S. Navy and Naval Reserves. Her nursing knowledge and experience in both the hospital and clinic settings, as well as oncology medical sales and product development, has been instrumental in promoting positive relations with partners, vendors, and distributors. 

Carrie is a Certified Infusion Nurse and a member of the Infusion Nurses Society. She earned a Bachelor of Science degree in Nursing from Rivier University and earned her Master’s in Business Administration from Rivier University. Carrie resides in New Hampshire with her husband and 2 children.

Paul A. Gendron joined the board in May 2019 after serving as a financial consultant to the Company; assisting with accounting, internal control and financial reporting matters. Upon joining the board, Mr. Gendron was appointed Chairman of the Audit Committee and also serves on the Compensation Committee.

With more than 30 years of experience, Mr. Gendron previously was a client service partner with PricewaterhouseCoopers LLP where he held various leadership roles serving global public and private multibillion-dollar corporations. Leadership assignments included North Texas Market Assurance Leader from 2009 until 2014, U.S. Assurance Talent Transformation Leader from 2014 until 2016, and Southwest Region Technology Practice Risk Management Leader. In his market assurance leadership role, Mr. Gendron led the Assurance practice in the Dallas, Fort Worth, Austin and Little Rock offices; providing services in internal and external audit, risk and information technology assurance, and accounting and capital markets advisory. His areas of strength include board governance, project management, risk management, executive management, public offerings, and mergers and acquisitions.

Mr. Gendron is a CPA and holds a Bachelor of Business Administration in Accounting degree from the University of Texas at Austin. He has served on non-profit boards during his career as well as the Accounting Advisory Council at the University of Texas at Austin. 

Gregg O. Lehman has been a member of the Company's Board of Directors since May 8, 2014, and has served as Executive Chairman and head of the Office of the President, as described under "Board of Directors and Committees of the Board of Directors" below, since May 18, 2017.  Dr. Lehman is a nationally recognized leader in population health management and has more than 28 years' experience in the health care industry. Dr. Lehman has served as Chief Executive Officer of EB Employee Solutions, LLC, a company that provides a fully integrated employer portal that includes health benefit cost reduction strategies and a “high tech, smart touch” wellness program. Dr. Lehman was previously President and Chief Executive Officer of MGC Diagnostics Corporation, a leading cardio-respiratory diagnostic company from July 2011 until May 2014. Dr. Lehman served as President and Chief Executive Officer of Health Fitness Corporation, a population health management company based in Minneapolis, MN, from 2007 through 2010. Dr. Lehman has held numerous senior-level executive and governance positions in the medical and education industries including President and Chief Executive Officer of INSPIRIS, Inc., a Nashville-based specialty care medical management company. Dr. Lehman also was President and Chief Executive Officer of Gordian Health Solutions, Inc., a health management company, and President and Chief Executive Officer of the National Business Coalition on Health (NBGH) in Washington, D.C., and as President of Taylor University in Indiana. Dr. Lehman has worked with the Health Care Purchasing Institute through Academy Health, the eHealth Initiative, the National Quality Forum, the National Patient Safety Foundation, and other purchasing/quality organizations that promote value-based purchasing and market-based reform. Dr. Lehman has a Doctorate and a Master of Science degree in higher education administration, with a minor in finance and economics from Purdue University and a Bachelor of Science in business management and marketing from Indiana University.

Dr. Lehman brings almost 40 years of experience in senior management positions with healthcare corporations and the management expertise and leadership abilities developed during his service in senior executive roles.

Darrel Montgomery has been a member of the Company’s Board of Directors since June 2017 and currently serves as Chair of the Nominating Governance Committee. Mr, Montgomery also services on the Compensation Committee as well as the Audit Committee.

Mr. Montgomery brings nearly 30 years in operational management, technology sales, mergers & acquisitions, consulting experience and leadership abilities developed during his career as an executive. Mr. Montgomery began his business career at Gemini Consulting as a senior consultant leading client teams in telecommunications, computer services, banking, and retail in both the United States and Europe. Mr. Montgomery spent 20 distinguished years at Dell Services, now NTT Services, where he worked with large enterprises as well as small companies principally focused on strategy and IT infrastructure. Mr. Montgomery served as Director of Operations, Global Software Solutions and held a senior role in the Commercial Solutions Group. Mr. Montgomery then served as an Executive Director in charge of establishing and leading the private equity channel working in Healthcare and Travel & Leisure industries. Mr. Montgomery previously served on the Board of Directors of Daegis, Inc.  Mr. Montgomery currently serves a Vice President, Global Strategic Engagements for Atos, a global IT services firm. Mr. Montgomery formerly served on active duty as a U.S. Marine Corps Infantry Officer and is a Trustee of the U.S. Naval Academy Athletic Foundation.

Mr. Montgomery earned a Bachelor of Science in History and General Engineering, with Distinction, from the U.S. Naval Academy and a Master of Business Administration from Harvard Business School.

Chris Sansone has been a member of the Company’s Board of Directors since June 2017; serving on the Company’s Compensation, Nominating Governance and Audit Committees.

With nearly 20 years of investment experience, Mr. Sansone’s insights into small cap markets combined with his long-standing investment as one of the Company’s largest stockholders, has helped improve the Company’s market awareness with existing and new investors. His various executive leadership roles throughout his career and experience and prospective as an analyst have proven to be invaluable to InfuSystem.

Mr. Sansone serves as a Managing Partner of Sansone Capital Management, LLC (together with its affiliates “Sansone”); providers of investment management services. Prior to founding Sansone Capital Management, LLC, Mr. Sansone held various roles involving small capitalization companies, including his position as an analyst and proprietary trader for Robotti & Company, LLC, a broker-dealer specializing in small- and micro-capitalization equities. Mr. Sansone served as a director on the board of EDAC Technologies from 2011 to 2013. Mr. Sansone has served as a director on the board of Decorator Industries from 2011 to 2012. Mr. Sansone was also a member of the committee of unsecured creditors in Palm Harbor Homes from 2010 to 2011 and served as a member on the OCA Incorporated Equity Committee from 2006 to 2007.

Mr. Sansone holds a Bachelor of Science in Economics from Pace University.

Scott Shuda has been a member of the Company’s Board of Directors since September 2016 and currently serves as the Chair of the Board as well as for the Compensation Committee. Mr. Shuda also serves on the Corporate Nominating Governance Committee. 

Mr. Shuda has extensive experience working with small companies, particularly public microcaps, helping them unlock value and achieve their full potential. His background as a corporate finance attorney, general counsel of a public company, and managing director of private investment funds focusing on healthcare and technology companies, provides InfuSystem with a deep understanding of the challenges facing small public companies, including the perspective of shareholders.

Mr. Shuda is a Managing Director and Co-founder of Meridian OHC Partners, LP and BlueLine Partners, LLC; investment firms that focus on publicly listed technology and healthcare companies. Mr. Shuda served as a director of Iridex Corporation (NASDAQ: IRIX), a global leader in ophthalmic laser systems, from 2012 to 2017 where he chaired Iridex’s Compensation Committee and served as a member of the Nominating and Governance Committee. Mr. Shuda rejoined the Iridex board in April 2019 and serves on the Audit and Compensation Committees. He served as a Director and Audit Committee member of MGC Diagnostics Corporation (formerly Angeion Corporation) (NASDAQ: MGCD), a global respiratory diagnostics company from 2010 to 2011. Prior to co-founding BlueLine Partners in April 2004, Mr. Shuda was General Counsel to Vicinity Corporation, an internet search company that went public in 2000 and was acquired by Microsoft in 2002. Prior to his employment with Vicinity, Mr. Shuda practiced law in California and New York, most recently in the Silicon Valley office of Latham & Watkins LLP. 

Mr. Shuda holds both Juris Doctor and Master of Business Administration degrees from Georgetown University.